Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China flag China · Delayed Price · Currency is CNY
17.18
-0.14 (-0.81%)
Oct 28, 2026, 10:54 AM CST

SHA:605369 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
71.551.51171.63109.13326.04310.99
Depreciation & Amortization
99.6899.6893.6283.9941.2321.81
Other Amortization
3.33.31.921.73--
Loss (Gain) From Sale of Assets
0.050.050.020.010.1-9.96
Asset Writedown & Restructuring Costs
26.1526.151.242.61.4810.43
Loss (Gain) From Sale of Investments
9.329.32-11.48-6.50.62-4.65
Provision & Write-off of Bad Debts
3.423.424.52-0.352.61-
Other Operating Activities
75.9825.77-0.5810.37-22.655.48
Change in Accounts Receivable
5.525.52-37.36-4.36-53.49-45.66
Change in Inventory
-5.07-5.07-21.613.75-12.03-51.69
Change in Accounts Payable
38.5438.5410.16-19.06-22.7117.54
Change in Other Net Operating Assets
2.372.371.472.8819.9213.41
Operating Cash Flow
324.16253.96210.38185.39282.75372.99
Operating Cash Flow Growth
51.59%20.71%13.48%-34.43%-24.19%54.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-132.62-111.6-109.61-121.82-172.18-275.56
Sale of Property, Plant & Equipment
0.880.1900.010.0511.85
Cash Acquisitions
--18.98-5.36-275.58--
Investment in Securities
-30.0349.81-87.86-0.1749.21-45
Other Investing Activities
0.17-7.30.14-40.18-7.98
Investing Cash Flow
-161.59-80.59-195.53-397.43-163.1-316.69

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-24560---
Total Debt Issued
22024560---
Short-Term Debt Repaid
--120-60---
Long-Term Debt Repaid
--16.21-8.63-0.59-0.69-0.35
Lease Payments
-16.21-16.21-8.63-0.59-0.69-0.35
Total Debt Repaid
-231.11-136.21-68.63-0.59-0.69-0.35
Net Debt Issued (Repaid)
-11.11108.79-8.63-0.59-0.69-0.35
Issuance of Common Stock
14.6314.63--1.6830.87
Repurchase of Common Stock
---38.88-5.12-0.69-
Common Dividends Paid
-37.25-65.68-81.23-90.1-155.43-144
Other Financing Activities
-32.667.510.5---
Financing Cash Flow
-66.3965.24-118.23-95.8-155.13-113.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-39.04-13.948.92.2830.88-5.76
Net Cash Flow
57.14224.67-94.49-305.56-4.59-62.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
191.54142.35100.7763.57110.5797.43
Free Cash Flow Growth
84.36%41.26%58.53%-42.51%13.49%-27.08%
Free Cash Flow Margin
16.14%12.53%9.04%6.52%7.53%8.16%
Free Cash Flow Per Share
-0.640.460.290.500.44
Levered Free Cash Flow
148.1789.0123.44-41.455.517.15
Unlevered Free Cash Flow
151.1592.5425.23-40.555.537.17
Free Cash Flow After Leases
175.33126.1492.1562.98109.8897.08

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
27.62729.6320.3198.0482.59
Change in Working Capital
34.7534.75-50.5-15.57-66.6938.9